Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
Celeste Silveira, Renato Guedes, Diana Maia, Rosário Curral, Rui Coelho
Psychiatry Investig. 2019;16(12):877-888.   Published online 2019 Dec 9     DOI: https://doi.org/10.30773/pi.2019.0106
Understanding the spectrum of non-motor symptoms in multiple sclerosis
Poornima D. E. Weerasinghe-Mudiyanselage, Joong-Sun Kim, Taekyun Shin, Changjong Moon
Neural Regeneration Research.2024; 19(1): 84.     CrossRef
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
Aurora Zanghì, Diana Ferraro, Graziella Callari, Paola Valentino, Franco Granella, Francesco Patti, Giacomo Lus, Simona Bonavita, Maria Claudia Moretti, Carlo Avolio, Emanuele D’Amico
Current Neuropharmacology.2024; 22(2): 339.     CrossRef
Improvement of the thalamocortical white matter network in people with stable treated relapsing–remitting multiple sclerosis over time
Abdulaziz Alshehri, Nikitas Koussis, Oun Al‐iedani, Ibrahim Khormi, Rodney Lea, Saadallah Ramadan, Jeannette Lechner‐Scott
NMR in Biomedicine.2024;[Epub]     CrossRef
Essential trace element levels in multiple sclerosis: Bridging demographic and clinical gaps, assessing the need for supplementation
Aleksandar Stojsavljević, Jovana Jagodić, Slađan Pavlović, Evica Dinčić, Jovana Kuveljić, Dragan Manojlović, Maja Živković
Journal of Trace Elements in Medicine and Biology.2024; 83: 127421.     CrossRef
Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, Víctor Echeverry-Alzate
International Journal of Molecular Sciences.2024; 25(5): 3010.     CrossRef
Article Review: Multiple Sclerosis
May Y. Al-ma'mouri Al-ma'mouri
Journal for Research in Applied Sciences and Biotechnology.2024; 3(1): 177.     CrossRef
Etiology and pathogenesis of mental disorders in patients with multiple sclerosis: anxiety, psychotic, and personality disorders, chemical addictions, pathological affect
P.A. Zimina, K.V. Gubskaya, L.V. Sinitsyna, Ya.V. Malygin, A.A. Akhpashev
Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery).2024; (2): 195.     CrossRef
Whole-Body Cryostimulation in Multiple Sclerosis: A Scoping Review
Angelo Alito, Jacopo Maria Fontana, Eleonora Franzini Tibaldeo, Federica Verme, Paolo Piterà, Elzbieta Miller, Riccardo Cremascoli, Andrea Brioschi, Paolo Capodaglio
Journal of Clinical Medicine.2024; 13(7): 2003.     CrossRef
Microstructural analysis of verbal fluency performance in relapsing-remitting multiple sclerosis based on the impact of disability level
Melis Buse Altun, Özlem Öge-Daşdöğen, Melih Tütüncü
Applied Neuropsychology: Adult.2024; : 1.     CrossRef
Health-related Quality of Life and Utilities among Lebanese Patients with Multiple Sclerosis: A cross-sectional study
Jalal Dahham, Mickaël Hiligsmann, Ingrid Kremer, Samia J. Khoury, Hala Darwish, Hassan Hosseini, Souheil Hallit, Silvia Evers, Rana Rizk
Multiple Sclerosis and Related Disorders.2024; : 105635.     CrossRef
The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis
Mohamed J. Saadh, Hani Moslem Ahmed, Zaid Khalid Alani, Rafil Adnan Hussein Al Zuhairi, Zainab M. Almarhoon, Hijaz Ahmad, Mohammed Ubaid, Nathera Hussin Alwan
NeuroMolecular Medicine.2024;[Epub]     CrossRef
The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools
Melanie Filser, Axel Buchner, Gereon Rudolf Fink, Stefan M. Gold, Iris-Katharina Penner
Journal of Neurology.2023; 270(1): 171.     CrossRef
Clinical correlates of state and trait anxiety in multiple sclerosis
Giulia Menculini, Lucia Gentili, Lorenzo Gaetani, Andrea Mancini, Silvia Sperandei, Elena Di Sabatino, Elena Chipi, Nicola Salvadori, Alfonso Tortorella, Lucilla Parnetti, Massimiliano Di Filippo
Multiple Sclerosis and Related Disorders.2023; 69: 104431.     CrossRef
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Stéphanie Andrade, Débora Nunes, Meghna Dabur, Maria J. Ramalho, Maria C. Pereira, Joana A. Loureiro
Pharmaceutics.2023; 15(1): 212.     CrossRef
CD83 Regulates the Immune Responses in Inflammatory Disorders
Bushra Riaz, S. Islam, Hye Ryu, Seonghyang Sohn
International Journal of Molecular Sciences.2023; 24(3): 2831.     CrossRef
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource
Rebecca L. Koch, Claudia Soler-Alfonso, Bridget T. Kiely, Akihiro Asai, Ariana L. Smith, Deeksha S. Bali, Peter B. Kang, Andrew P. Landstrom, H. Orhan Akman, T. Andrew Burrow, Jennifer L. Orthmann-Murphy, Deberah S. Goldman, Surekha Pendyal, Areeg H. El-G
Molecular Genetics and Metabolism.2023; 138(3): 107525.     CrossRef
Effects of Calorie Restriction on Multiple Sclerosis: A Review of the Preclinical and Clinical Studies
Parinaz Javanbakht, Fatemeh Taghizadeh, Fatemeh Shirani Takabi, Mohammadhassan Tajik, Saeideh Iranshahi, Parichehr Pasbakhsh, Iraj Ragerdi Kashani, Sina Mojaverrostami
Neurochemical Research.2023; 48(6): 1597.     CrossRef
Neuropsychiatric Status of Patients With Multiple Sclerosis Across Disease Duration Intervals
David E. Freedman, Jiwon Oh, Anthony Feinstein
The Journal of Neuropsychiatry and Clinical Neurosciences.2023; 35(3): 250.     CrossRef
Supporting people with multiple sclerosis: respecting their autonomy and managing risk
Ruth Isherwood
British Journal of Neuroscience Nursing.2023; 19(Sup1): S28.     CrossRef
The CLDN5 gene at the blood-brain barrier in health and disease
Yosuke Hashimoto, Chris Greene, Arnold Munnich, Matthew Campbell
Fluids and Barriers of the CNS.2023;[Epub]     CrossRef
Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses
Katarina Vesic, Aleksandar Gavrilovic, Nataša R Mijailović, Milica M Borovcanin
World Journal of Psychiatry.2023; 13(4): 161.     CrossRef
Neuropsychiatric Manifestations of Multiple Sclerosis and the Effects of Modern Disease-Modifying Therapies
Mohona Reza, Jonathan F. Cahill, Emily Federo Hungria, Laura Stanton, Michael Kritselis, John E. Donahue, Victoria Sanborn, Chuang-Kuo Wu
Advances in Psychiatry and Behavioral Health.2023; 3(1): 239.     CrossRef
Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
Steffeni Mountford, Maria Kahn, Preetha Balakrishnan, Elizabeth Jacyshyn-Owen, Markus Eberl, Benjamin Friedrich, Natalie Joschko, Tjalf Ziemssen
DIGITAL HEALTH.2023; 9: 205520762311735.     CrossRef
Mindfulness and Multiple Sclerosis: A Patient Guide
Samantha Fenner, John V. Rider
Archives of Physical Medicine and Rehabilitation.2023; 104(12): 2187.     CrossRef
Neuropsychiatric Manifestations of Tumefactive Demyelinating Lesion
Jennifer Hsu, Amanda Plein, Scott B. Mathis
American Journal of Psychiatry Residents' Journal.2023; 18(4): 9.     CrossRef
The psychological impact of the COVID-19 pandemic on people with multiple sclerosis
Vitalie Vacaras, Cristina Nistor, Andra Maria Schiopu, Cristiana Vacaras, Gheorghe-Eduard Marin, Dafin F. Muresanu
Multiple Sclerosis and Related Disorders.2023; 76: 104825.     CrossRef
Reduced clinical connectome fingerprinting in multiple sclerosis predicts fatigue severity
Lorenzo Cipriano, Emahnuel Troisi Lopez, Marianna Liparoti, Roberta Minino, Antonella Romano, Arianna Polverino, Francesco Ciaramella, Michele Ambrosanio, Simona Bonavita, Viktor Jirsa, Giuseppe Sorrentino, Pierpaolo Sorrentino
NeuroImage: Clinical.2023; 39: 103464.     CrossRef
Cognitive impairment in multiple sclerosis: “classic” knowledge and recent acquisitions
Chiara Piacentini, Ornella Argento, Ugo Nocentini
Arquivos de Neuro-Psiquiatria.2023; 81(06): 585.     CrossRef
Effectiveness of dialectical behavior therapy as a transdiagnostic treatment for improving cognitive functions: a systematic review
CV Vijayapriya, Rameshbabu Tamarana
Research in Psychotherapy: Psychopathology, Process and Outcome.2023;[Epub]     CrossRef
Eating Attitude in Multiple Sclerosis
Yılmaz İNANÇ, Celaleddin TURGUT, Tuğba KAYA
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi.2023; 18(2): 60.     CrossRef
Artificial Intelligence: Deciphering the Links between Psychiatric Disorders and Neurodegenerative Disease
George B. Stefano, Pascal Büttiker, Simon Weissenberger, Tobias Esch, Maren M. Michaelsen, Martin Anders, Jiri Raboch, Radek Ptacek
Brain Sciences.2023; 13(7): 1055.     CrossRef
Depression in multiple sclerosis: Clinical case review and grand rounds
Harkishan Mamtani, Kshiteeja Jain, Sundarnag Ganjekar, M Netravathi, Geetha Desai
Journal of Psychiatry Spectrum.2023; 2(2): 122.     CrossRef
Psychological symptoms in Multiple Sclerosis and the role of marital status: results from a retrospective single-center study
Viviana Lo Buono, Francesco Corallo, Lilla Bonanno, Deborah Pria, Marcella Di Cara, Rosanna Palmeri, Giangaetano D'Aleo, Carmela Rifici, Edoardo Sessa, Silvia Marino, Maria Cristina De Cola
Multiple Sclerosis and Related Disorders.2023; 79: 105051.     CrossRef
The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in Saudi Arabia: a cross-sectional multicentered study
Anas M. Alswat, Bsaim A. Altirkistani, Anas R. Alserihi, Osama K. Baeshen, Eythar S. Alrushid, Joud Alkhudair, Abdulaziz A. Aldbas, Osama M. Wadaan, Ahmad Alsaleh, Yaser M. Al Malik, Ahmad A. Abulaban, Seraj Makkawi
Frontiers in Psychiatry.2023;[Epub]     CrossRef
A Grave Set of Diagnoses: A Case of Mania with Comorbid Autoimmune Thyroiditis Precipitated by Multiple Sclerosis Treatment
Han Yue, Sejal B. Shah, Katherine L. Modzelewski, Mark Knobel, Frank Copeli, Larkin Kao
Harvard Review of Psychiatry.2023; 31(5): 242.     CrossRef
Symptom Management Among Multiple Sclerosis Care Partners in Canada
Katherine L. Cardwell, Taylor A. Hume, Odessa J. McKenna, Lara A. Pilutti, Afolasade Fakolade
International Journal of MS Care.2023; 25(6): 281.     CrossRef
The effectiveness of telehealth interventions for people with multiple sclerosis: A systematic review and meta-analysis protocol
Reza Heidari-Soureshjani, Mojtaba Daneshvar, Tayeb Mohammadi, Reza Negarandeh, Leila Sayadi
DIGITAL HEALTH.2023;[Epub]     CrossRef
Akute psychotische Störung als erste klinische Manifestation einer Multiplen Sklerose – eine Kasuistik
Sharmili Edwin Thanarajah, Hannah Wendy, Andreas Reif, Christine Reif-Leonhard
Der Nervenarzt.2022; 93(1): 77.     CrossRef
Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series
Michel Sabe, Othman Sentissi
International Journal of Psychiatry in Clinical Practice.2022; 26(3): 287.     CrossRef
Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis
Seungmin Kim, Eun-Jae Lee, Keon-Woo Kim, Dayoung Seo, Seongshin Moon, Kwang-Kuk Kim, Young-Min Lim
Multiple Sclerosis and Related Disorders.2022; 58: 103500.     CrossRef
A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study
Marion Azoulai, Tiphaine Lévy-Heidmann, Valentin Morisseau, Ophélie Wilczynski, Hoa H Le, Carol Jamieson, Leigh E. Charvet, Lauren B Krupp, Lindsey Lair
Multiple Sclerosis and Related Disorders.2022; 59: 103637.     CrossRef
The bipolarity of Alberto Santos-Dumont: flights and falls of the “Father of Aviation”
Elie Cheniaux
Jornal Brasileiro de Psiquiatria.2022; 71(1): 63.     CrossRef
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project
Maria Grazia Celani, Francesco Nonino, Kathryn Mahan, Massimiliano Orso, Ben Ridley, Elisa Baldin, Angelo Antonio Bignamini, Roberto D'Amico, Teresa Anna Cantisani, Cinzia Colombo, Fary Khan, Sascha Köpke, Joanna Laurson-Doube, Catherine Schvarz, Carolyn
Multiple Sclerosis and Related Disorders.2022; 60: 103688.     CrossRef
Mouse models of immune dysfunction: their neuroanatomical differences reflect their anxiety-behavioural phenotype
Darren J. Fernandes, Shoshana Spring, Christina Corre, Andrew Tu, Lily R. Qiu, Christopher Hammill, Dulcie A. Vousden, T. Leigh Spencer Noakes, Brian J. Nieman, Dawn M. E. Bowdish, Jane A. Foster, Mark R. Palmert, Jason P. Lerch
Molecular Psychiatry.2022; 27(7): 3047.     CrossRef
The effect of peer education based on Pender’s health promotion model on quality of life, stress management and self-efficacy of patients with multiple sclerosis: a randomized controlled clinical trial
Mostafa Bijani, Maryam Niknam, Shanaz Karimi, Zeinab Naderi, Azizallah Dehghan
BMC Neurology.2022;[Epub]     CrossRef
Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross‐sectional case–control study
Amirali Ghahremani, Sahar Mosa Farkhani, Mahsa Baniasadi, Seyed Kaveh Hojjat, Hasan Namdar Ahmadabad, Davoud Salarbashi, Sepideh Elyasi, Najmeh Davoodian
Brain and Behavior.2022;[Epub]     CrossRef
Emotional disorders associated to multiple sclerosis and psychological interventions: a literature review
Alina Schenk, Cosmin Octavian Popa, Cristiana Manuela Cojocaru
Acta Marisiensis - Seria Medica.2022; 68(1): 6.     CrossRef
Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
Paola Zaratin, Brenda Banwell, Timothy Coetzee, Giancarlo Comi, Anthony Feinstein, Robert Hyde, Marco Salvetti, Kathryn Smith
Multiple Sclerosis Journal - Experimental, Translational and Clinical.2022; 8(2): 205521732210991.     CrossRef
Barriers to quality of life in patients with multiple sclerosis: a qualitative study
Zahra Hosseini, Atefeh Homayuni, Masoud Etemadifar
BMC Neurology.2022;[Epub]     CrossRef
Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis
Patrícia de Morais Ferreira Brandão, Tayla Borges Lino, Renata Terra de Oliveira, Andrelisa Vendrami Parra, Paulo Henrique Muleta Andrade, Gustavo Christofoletti
Revista Brasileira de Enfermagem.2022;[Epub]     CrossRef
Association of Exposure to Particulate Matters and Multiple Sclerosis: A Systematic Review and Meta-Analysis
Fatemeh Lotfi, Marjan Mansourian, Omid Mirmoayyeb, Soroush Najdaghi, Vahid Shaygannejad, Nafiseh Esmaeil
Neuroimmunomodulation.2022; 29(1): 21.     CrossRef
Major depressive disorder: A rare presentation of multiple sclerosis
Carolina Alves Rodrigues, Mafalda Delgado Soares, Gustavo Jesus, Filipa Ladeira
Psychiatry Research Case Reports.2022; 1(2): 100030.     CrossRef
Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany
Preetha Balakrishnan, Jannis Groenberg, Elizabeth Jacyshyn-Owen, Markus Eberl, Benjamin Friedrich, Natalie Joschko, Tjalf Ziemssen
Journal of Personalized Medicine.2022; 12(7): 1100.     CrossRef
Medical cannabis in multiple sclerosis
Simon Erridge, Mikael H Sodergren, Mark W Weatherall
British Journal of Neuroscience Nursing.2022; 18(Sup3): S28.     CrossRef
Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment
Angela Dziedzic, Joanna Saluk
International Journal of Molecular Sciences.2022; 23(22): 14478.     CrossRef
Prediction of Cognitive Decline by Behavioral Symptoms in Neuropsychiatric Disorders
Majid Barekatain, Sona Sadeghpour, Fatemeh Rajabi, Mohammad Reza Maracy
Iranian Journal of Psychiatry and Behavioral Sciences.2022;[Epub]     CrossRef
Speech/Language Comprehension in the Context of Language Difficulties in Persons with Neurocognitive Disorders
Lucie Nohová, Kateřina Vitásková
Listy klinické logopedie.2022; 6(2): 4.     CrossRef
Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health
Weixi Kang
Journal of Clinical Medicine.2022; 11(24): 7483.     CrossRef
Bipolar spectrum disorders in neurologic disorders
Anna Digiovanni, Paola Ajdinaj, Mirella Russo, Stefano L. Sensi, Marco Onofrj, Astrid Thomas
Frontiers in Psychiatry.2022;[Epub]     CrossRef
Multiple sclerosis and aging: comorbidity and treatment challenges
Aiora Ostolaza, Jon Corroza, Teresa Ayuso
Multiple Sclerosis and Related Disorders.2021; 50: 102815.     CrossRef
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review
Bryan E. Davis, Lynsey Lakin, Cherie C. Binns, Keisha M. Currie, Mary R. Rensel
Neurology and Therapy.2021; 10(1): 99.     CrossRef
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review
Lynsey Lakin, Bryan E. Davis, Cherie C. Binns, Keisha M. Currie, Mary R. Rensel
Neurology and Therapy.2021; 10(1): 75.     CrossRef
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis
Giulia Menculini, Elena Chipi, Federico Paolini Paoletti, Lorenzo Gaetani, Pasquale Nigro, Simone Simoni, Andrea Mancini, Nicola Tambasco, Massimiliano Di Filippo, Alfonso Tortorella, Lucilla Parnetti
International Journal of Molecular Sciences.2021; 22(9): 4440.     CrossRef
Mindfulness- and Acceptance-Based Interventions for Symptom Reduction in Individuals With Multiple Sclerosis: A Systematic Review and Meta-Analysis
Areum Han
Archives of Physical Medicine and Rehabilitation.2021; 102(10): 2022.     CrossRef
Patient and neurologist preferences in the UK for relapsing–remitting multiple sclerosis treatments: findings from a discrete choice experiment
Tom Tencer, Oliver Will, Jinender Kumar, M. Janelle Cambron-Mellott, deMauri S. Mackie, Kathleen Beusterien
Current Medical Research and Opinion.2021; 37(9): 1589.     CrossRef
Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series
Payam Amini, Amir Almasi-Hashiani, Mohammad Ali Sahraian, Masood Najafi, Sharareh Eskandarieh
BMC Neurology.2021;[Epub]     CrossRef
Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation
Edgardo Cristiano, Patricio Abad, Jefferson Becker, Adriana Carrá, Jorge Correale, José Flores, Manuel Fruns, Orlando Garcea, Juan Garcia Bónitto, Fernando Gracia, Fernando Hamuy, Cárlos Navas, Liliana Patrucco, Víctor Rivera, Merced Velazquez, Juan Ignac
Journal of the Neurological Sciences.2021; 429: 118072.     CrossRef
Mood Disorders
Shae Datta, Uma Suryadevara, Josepha Cheong
CONTINUUM: Lifelong Learning in Neurology.2021; 27(6): 1712.     CrossRef
Psychosis: a rare onset symptom of pediatric multiple sclerosis
Pınar Özbudak, Hakan Erçelebi, Kıvılcım Gücüyener
Neurocase.2021; 27(6): 474.     CrossRef
The Neuroprotective Properties, Functions, and Roles of Cannabis sativa in Selected Diseases Related to the Nervous System
Onesimus Mahdi, Mohamad T.H. Baharuldin, Nurul Huda M. Nor, Samaila M. Chiroma, Saravanan Jagadeesan, Mohamad A.M. Moklas
Central Nervous System Agents in Medicinal Chemistry.2021; 21(1): 20.     CrossRef
Anxiety in neurological practice
Yu.P. Sivolap, Y.E. Azimova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2020; 120(5): 165.     CrossRef
The Influence of Depression and Anxiety on Neurological Disability in Multiple Sclerosis Patients
Vitalie Văcăraș, Veronica Văcăraș, Cristina Nistor, Daniela Văcăraș, Adrian Nicolae Opre, Petronela Blaga, Dafin F. Mureșanu
Behavioural Neurology.2020; 2020: 1.     CrossRef
Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study
Dennis van der Meer, Justo Pinzón-Espinosa, Bochao D. Lin, Joeri K. Tijdink, Christiaan H. Vinkers, Sinan Guloksuz, Jurjen J. Luykx
BJPsych Open.2020;[Epub]     CrossRef
Cognitive Performance in Relapsing-Remitting Multiple Sclerosis: At Risk or Impaired?
Marta Altieri, Mariangela Fratino, Ilaria Maestrini, Claudia Dionisi, Rosanna Annecca, Edoardo Vicenzini, Vittorio Di Piero
Dementia and Geriatric Cognitive Disorders.2020; 49(6): 539.     CrossRef